ÌÇÐÄ´«Ã½

Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
ÌÇÐÄ´«Ã½

Experience with burdens of diabetes device use that affect uptake and optimal use in people with type 1 diabetes.

ÌÇÐÄ´«Ã½

Experience with burdens of diabetes device use that affect uptake and optimal use in people with type 1 diabetes. Endocrine connections Tanenbaum, M. L., Commissariat, P. V. 2023

Abstract

Diabetes technology continues to advance, with more individuals with type 1 diabetes (T1D) adopting insulin pumps, continuous glucose monitoring (CGM), and automated insulin delivery (AID) systems that integrate real-time glucose data with an algorithm to assist with insulin dosing decisions. These technologies are linked with benefits to glycemic outcomes (e.g., increased time in target range), diabetes management behaviors, and quality of life. However, current devices and systems are not without barriers and hassles for the user. The intent of this review is to describe the personal challenges and reactions that users experience when interacting with current diabetes technologies, which can affect their acceptance and motivation to engage with their devices. This review will discuss user experiences and strategies to address three main areas: 1) the emotional burden of utilizing a wearable device; 2) the perceived and experienced negative social consequences of device use; and 3) the practical challenges of wearing devices.

View details for

View details for